Intercept Withdraws Ocaliva From US, The Last Market For The PBC Drug

Removal Was Likely After Multiple Safety Alerts

 
• By Mandy Jackson
  
Ocaliva already has had its approval revoked in the EU (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Rare Diseases

More from Scrip